SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
-
Y. Escobar Álvarez [1] ; R. de las Peñas Bataller [6] ; J. Perez Altozano [2] ; S. Ros Martínez [7] ; A. Sabino Álvarez [3] ; A. Blasco Cordellat [8] ; E. Brozos Vázquez [9] ; J. Corral Jaime [4] ; I. García Escobar [10] ; C. Beato Zambrano [5]
-
[1] Hospital General Universitario Gregorio Marañón
Hospital General Universitario Gregorio Marañón
Madrid, España
-
[2] Hospital Virgen de los Lirios
Hospital Virgen de los Lirios
Alcoy, España
-
[3] Hospital Universitario Puerta del Mar
Hospital Universitario Puerta del Mar
Cádiz, España
-
[4] Clínica Universitaria de Navarra
Clínica Universitaria de Navarra
Pamplona, España
-
[5] Hospital de Jerez
Hospital de Jerez
Jerez de la Frontera, España
-
[6] Consorcio Hospitalario Provincial de Castellón
-
[7] Hospital Universitario Virgen de la Arrixaca
-
[8] Consorcio Hospital General Universitario Valencia
-
[9] Hospitalario Clínico Universitario de Santiago de Compostela
-
[10] Hospital General Universitario Virgen de las Nieves
-
- Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 23, Nº. 5 (May), 2021 (Ejemplar dedicado a: SEOM clinical guidelines 2020), págs. 931-939
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
Anaemia is defined by the presence of haemoglobin (Hb) levels < 13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron deficiency. Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has also been associated with a poorer response to anti-tumour treatment and lower survival. Basic diagnostic tests for anaemia are simple and should be a routine part of clinical practice. These guidelines review the available evidence on the use of different therapies for treating anaemia: erythropoiesis-stimulating agents, iron supplements, and transfusion of blood products.
